CLEAR LABELS Act

This legislation proposes to amend the Federal Food, Drug, and Cosmetic Act to increase transparency regarding the origins of prescription and over-the-counter medications. If enacted, the bill would require drug labels to clearly identify the original manufacturer of the product and provide information regarding its movement through the supply chain. This change aims to give healthcare providers and consumers more specific data about where their medications are produced and how they reach the market.

By requiring these disclosures, the bill seeks to address concerns regarding drug safety and the reliability of the pharmaceutical supply chain. Currently, it can be difficult for consumers to determine the exact source of a drug's active ingredients or the location of the primary manufacturing facility. This proposal would mandate that such details be accessible, potentially helping the public and regulators better track the quality and security of the nation's drug supply.